Nucleic Acids Research, 2003, Vol. 31, No. 3 1024-1032
© 2003 Oxford University Press
Ribonuclease inhibitor as an intracellular sentry
1 Department of Biochemistry and 2 Department of Chemistry, University of Wisconsin–Madison, Madison, WI 53706, USA
*To whom correspondence should be addressed at Department of Biochemistry, University of Wisconsin–Madison, 433 Babcock Drive, Madison, WI 53706-1544, USA. Tel: +1 608 262 8588; Fax: +1 608 262 3453; Email: raines{at}biochem.wisc.edu
Present address:
Marcia C. Haigis, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
Onconase® (ONC) is a homolog of RNase A that is in clinical trials as a cancer chemotherapeutic agent. The toxicity of ONC and RNase A variants relies on their ability to evade the cytosolic ribonuclease inhibitor protein (RI) and degrade cellular RNA. We find that these ribonucleases are more toxic for more rapidly growing cells. The enhanced cytotoxicity does not arise from variation in the endogenous level of RI, which is virtually constant. Overproduction of RI diminishes the potency of toxic RNase A variants, but has no effect on the cytotoxicity of ONC. Thus, RI constrains the cytotoxicity of RNase A. These data provide new insights for the development of an optimal ribonuclease-based cancer chemotherapy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. Fuchs, T. J. Rutkoski, V. M. Kung, R. T. Groeschl, and R. T. Raines Increasing the potency of a cytotoxin with an arginine graft Protein Eng. Des. Sel., October 22, 2007; (2007) gzm051v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rodriguez, G. Torrent, M. Bosch, F. Rayne, J.-F. Dubremetz, M. Ribo, A. Benito, M. Vilanova, and B. Beaumelle Intracellular pathway of Onconase that enables its delivery to the cytosol J. Cell Sci., April 15, 2007; 120(8): 1405 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Fuchs and R. T. Raines Polyarginine as a multifunctional fusion tag Protein Sci., June 1, 2005; 14(6): 1538 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Korn, S. R. Scholz, O. Gimadutdinow, R. Lurz, A. Pingoud, and G. Meiss Interaction of DNA Fragmentation Factor (DFF) with DNA Reveals an Unprecedented Mechanism for Nuclease Inhibition and Suggests That DFF Can Be Activated in a DNA-bound State J. Biol. Chem., February 18, 2005; 280(7): 6005 - 6015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Castella, H. Benedetti, R. de Llorens, J.-L. Dacheux, and F. Dacheux Train A, an RNase A-Like Protein Without RNase Activity, Is Secreted and Reabsorbed by the Same Epididymal Cells under Testicular Control Biol Reprod, November 1, 2004; 71(5): 1677 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Monti and G. D'Alessio Cytosolic RNase Inhibitor Only Affects RNases with Intrinsic Cytotoxicity J. Biol. Chem., September 17, 2004; 279(38): 39195 - 39198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sica, A. Di Fiore, A. Merlino, and L. Mazzarella Structure and Stability of the Non-covalent Swapped Dimer of Bovine Seminal Ribonuclease: AN ENZYME TAILORED TO EVADE RIBONUCLEASE PROTEIN INHIBITOR J. Biol. Chem., August 27, 2004; 279(35): 36753 - 36760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kumar, M. Brady, and R. Shapiro Selective abolition of pancreatic RNase binding to its inhibitor protein PNAS, January 6, 2004; 101(1): 53 - 58. [Abstract] [Full Text] [PDF]
|
|